908 Devices (MASS) Depreciation and Depletion (2024 - 2025)
908 Devices (MASS) reported Depreciation and Depletion of $400000.0 for Q4 2025, up 100.0% year-over-year from $200000.0 in Q4 2024, and little changed on a QoQ basis from $400000.0 in Q3 2025.
908 Devices (MASS) has 2 years of Depreciation and Depletion data on file, last reported at $400000.0 in Q4 2025.
- Quarterly Depreciation and Depletion rose 100.0% year-over-year to $400000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.3 million (changed N/A YoY) and the FY2025 annual result came in at $1.3 million, up 30.0% from the prior year.
- Depreciation and Depletion was little changed at $400000.0 in Q4 2025 per MASS's latest filing, from $400000.0 in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $400000.0 in Q3 2025 and bottomed at $200000.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 308.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 29.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | 908 Devices | 314.43 Mn | 202.69 Mn | 6.88 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 400,000.00 |
| Dec 31, 2025 | 400,000.00 |
| Sep 30, 2025 | 400,000.00 |
| Sep 30, 2025 | 400,000.00 |
| Dec 31, 2024 | 200,000.00 |
| Dec 31, 2024 | 200,000.00 |
| Sep 30, 2024 | 300,000.00 |
| Sep 30, 2024 | 300,000.00 |